Erivedge


Indications and Reactions:

Role Indications Reactions
Primary
Basal Cell Carcinoma 43.8%
Product Used For Unknown Indication 24.6%
Hypertension 4.9%
Skin Cancer 4.0%
Hiv Infection 2.2%
Anxiety 1.8%
Cardiac Failure Congestive 1.8%
Constipation 1.8%
Gastrooesophageal Reflux Disease 1.8%
Pain 1.8%
Type 2 Diabetes Mellitus 1.8%
Acute Myocardial Infarction 1.3%
Blood Pressure 1.3%
Hypothyroidism 1.3%
Muscle Spasms 1.3%
Atrial Fibrillation 0.9%
Benign Prostatic Hyperplasia 0.9%
Blood Cholesterol 0.9%
Coronary Artery Disease 0.9%
Depression 0.9%
Death 23.8%
Weight Decreased 17.8%
Muscle Spasms 14.9%
Squamous Cell Carcinoma 5.9%
Disease Progression 3.0%
Liver Function Test Abnormal 3.0%
Myalgia 3.0%
Myocardial Infarction 3.0%
Nausea 3.0%
Syncope 3.0%
Basal Cell Carcinoma 2.0%
Cardiac Failure Congestive 2.0%
Fatigue 2.0%
Hepatic Enzyme Increased 2.0%
Hypophagia 2.0%
Lymphoma 2.0%
Neoplasm Malignant 2.0%
Renal Impairment 2.0%
Thrombosis 2.0%
Visual Impairment 2.0%
Secondary
Basal Cell Carcinoma 23.5%
Acute Myocardial Infarction 11.8%
Metastases To Liver 11.8%
Pancreatic Neuroendocrine Tumour Metastatic 11.8%
Von Hippel-lindau Disease 11.8%
Coronary Artery Disease 7.8%
Cardiac Failure Congestive 3.9%
Hyperlipidaemia 3.9%
Malignant Melanoma 3.9%
Type 2 Diabetes Mellitus 3.9%
Basal Cell Naevus Syndrome 2.0%
Constipation 2.0%
Neoplasm Skin 2.0%
Pancreatic Neuroendocrine Tumour Metastatic 23.1%
Lactic Acidosis 15.4%
Drug Effect Decreased 7.7%
Muscle Spasms 7.7%
Myocardial Infarction 7.7%
Nausea 7.7%
Pyrexia 7.7%
Upper Respiratory Tract Infection 7.7%
Visual Impairment 7.7%
Weight Decreased 7.7%

Drug Data